Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 24 December 1999:
Vol. 286. no. 5449, p. 2431
DOI: 10.1126/science.286.5449.2431
Prev | Table of Contents | Next

News of the Week

CANCER RESEARCH:
Bracing p53 for the War on Cancer

Elizabeth Pennisi

The tumor suppressor protein p53 helps short-circuit tumor formation by preventing cells that have suffered malignant mutations from continuing to grow. Yet the p53 gene itself is susceptible to damage, which is thought to contribute to the development of half of all cancers, including common ones such as skin, breast, and colon cancers. Now, in work described on page 2507, cancer biologists have identified a drug that may be able to restore the normal function of some mutated p53 proteins and might therefore point the way to a new kind of cancer therapy.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Shoring Up Mutant p53.
(2000)
Journal Watch Dermatology 2000, 10
   Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)